Core Insights - Jade Biosciences is focused on developing best-in-class therapeutics for various autoimmune diseases [3] - The company has three programs developed in collaboration with Paragon Therapeutics, which specializes in high affinity binding monoclonal antibodies and half-life extension technology [3] Company Overview - Jade Biosciences aims to leverage high affinity binding and half-life extension technology to enhance therapeutic efficacy [4] - The dual benefits of this approach include more complete inhibition of targets throughout the dosing interval and reduced patient burden through extended dosing intervals [4]